• Evolution of Virus inactivation methods in manufacture of biologics

  • 2024/05/29
  • 再生時間: 19 分
  • ポッドキャスト

Evolution of Virus inactivation methods in manufacture of biologics

  • サマリー

  • Viral contamination is a common threat to all animal- and human-derived biopharmaceuticals. A virus is essentially an infectious agent that is capable of infecting a host cell and to copy itself. Viruses consist of nucleic acid (DNA or RNA) in a protein coat/capsid. Those with an outer lipid layer are referred to as enveloped viruses; those without one are classified as nonenveloped or naked viruses.


    Visit Site>> Click Here

    続きを読む 一部表示
activate_samplebutton_t1

あらすじ・解説

Viral contamination is a common threat to all animal- and human-derived biopharmaceuticals. A virus is essentially an infectious agent that is capable of infecting a host cell and to copy itself. Viruses consist of nucleic acid (DNA or RNA) in a protein coat/capsid. Those with an outer lipid layer are referred to as enveloped viruses; those without one are classified as nonenveloped or naked viruses.


Visit Site>> Click Here

Evolution of Virus inactivation methods in manufacture of biologicsに寄せられたリスナーの声

カスタマーレビュー:以下のタブを選択することで、他のサイトのレビューをご覧になれます。